Now, more than 114 million Chinese patients can benefit from a highly effective and potentially more comfortable treatment through a needle-free injection technology from QS Medical Technology Co., LTD (QS).
These high-quality, needle-free injectors utilize Makrolon® Rx1805 polycarbonate. This medical-grade material offers durability, processability and design flexibility to the insulin-delivery interface and medicine ampoules. It ensures that the drug-delivery component can consistently puncture through the plug of an insulin ampoule, and also allows for the drug-sampling needle and the protective cover of the drug suction apparatus to be injection molded in one shot.
Other benefits of Makrolon® Rx1805 polycarbonate include:
- Resistant to cracking against lipids and radiation sterilization
- Ability to ensure high productivity and efficiency during the molding of the ampoule bottles, and maintain stability under different application environments
- Biocompatible and complies with multiple requirements of ISO 10993
- High impact resistance
- Accuracy in molding size
This innovative needle-free technology makes life easier and more comfortable for millions of diabetes patients in China and around the world — no needle required.
For more information, email us: firstname.lastname@example.org.
Makrolon® is a registered trademark of the Covestro group.